Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to determine the effects of Pulmonary Rehabilitation (PR) on shortness of breath, exercise capacity, symptom control, mental health, cognitive function, and quality of life in patients with Idiopathic Pulmonary Fibrosis (IPF). Pulmonary rehabilitation has already been shown to benefit patients with other chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD). We believe that pulmonary rehabilitation will benefit patients with IPF as well.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 4, 2008
CompletedFirst Posted
Study publicly available on registry
June 6, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2010
CompletedMarch 29, 2017
March 1, 2017
1.9 years
June 4, 2008
March 27, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Exercise capacity
6 weeks and again at 6 months
Secondary Outcomes (5)
Cognition
6 weeks and again at 6 months
Quality of life
6 weeks and again at 6 months
Fatigue
6 weeks and again at 6 months
Anxiety
6 weeks and again at 6 months
Depression
6 weeks and again at 6 months
Study Arms (1)
1
EXPERIMENTALInterventions
Pulmonary rehabilitation is a multi-disciplinary program that includes exercise training, disease education, psychosocial education (e.g., stress management, coping with chronic illness) and nutrition education.
Eligibility Criteria
You may qualify if:
- Age 40 years or older
- Diagnosis of IPF according to American Thoracic Society criteria
You may not qualify if:
- Patients who have completed a PR program within the last two years
- Patients with unstable medical conditions that would make PR unsafe
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Jewish Healthlead
- Mordecai Palliative Care Research Fundcollaborator
Study Sites (1)
National Jewish Medical and Research Center
Denver, Colorado, 80206, United States
Related Publications (1)
Swigris JJ, Fairclough DL, Morrison M, Make B, Kozora E, Brown KK, Wamboldt FS. Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care. 2011 Jun;56(6):783-9. doi: 10.4187/respcare.00939. Epub 2011 Feb 11.
PMID: 21333082DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeff Swigris, DO, MS
National Jewish Medical and Research Center (Jeffrey J. Swigris, DO, MS; Assistant Professor of Medicine)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 4, 2008
First Posted
June 6, 2008
Study Start
April 1, 2008
Primary Completion
March 1, 2010
Study Completion
March 1, 2010
Last Updated
March 29, 2017
Record last verified: 2017-03